Binningen, Switzerland

Giulio Navarra

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: University of Basel. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Giulio Navarra. Retrieved from https://idiyas.com/inventor/giulio-navarra

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Giulio Navarra in Neurological Disease Treatment

Introduction

Giulio Navarra is an accomplished inventor based in Binningen, Switzerland. He has made significant contributions to the field of neuroscience through his innovative work on carbohydrate ligands. His research focuses on the interaction between these ligands and antibodies associated with neurological diseases.

Latest Patents

Giulio Navarra holds a patent for "Carbohydrate ligands that bind to antibodies against glycoepitopes of glycosphingolipids." This invention relates to carbohydrate ligands that mimic glycoepitopes found in glycosphingolipids of the nervous system. These ligands are particularly relevant for diagnosing and treating neurological diseases linked to anti-glycan antibodies. The patent outlines compounds that can be used therapeutically, including polymers that incorporate these carbohydrate ligands.

Career Highlights

Navarra has worked at prestigious institutions such as Universität Basel. His research has contributed to a deeper understanding of the role of glycosphingolipids in neurological conditions. His innovative approach has opened new avenues for therapeutic interventions in this critical area of medicine.

Collaborations

Giulio Navarra has collaborated with notable colleagues, including Ruben Herrendorff and Beat Ernst. These partnerships have enhanced his research and contributed to the advancement of knowledge in the field of glycosphingolipids and their implications in neurological diseases.

Conclusion

Giulio Navarra's work exemplifies the intersection of innovation and medical research. His contributions to the understanding and treatment of neurological diseases through carbohydrate ligands are noteworthy. His patent reflects a significant advancement in the field, promising new diagnostic and therapeutic options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…